Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialMeinolf Karthaus, Peter Reichardt, David Irwin et al.|Annals of Oncology|2005Cited by 223
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).Saverio Cinieri, Uğur Çoşkun, Arlene Chan et al.|Journal of Clinical Oncology|2014Cited by 3